C4 – Cervical Cancer Control
  • About Us
  • Projects
  • People
  • Publications
    Reports 2022 Publications 2021 Publications 2020 Publications 2019 Publications(current) 2018 Publications 2017 Publications
  • Partners
  • CRE Member Activities
    News & Events Media Committee Memberships Conference Presentations
  • Contact Us

2019 Publications

  • Management and long-term outcomes of women with adenocarcinoma in situ of the cervix: A retrospective study. The Australian and New Zealand Journal of Obstetrics and Gynaecology (ANZJOG).
  • Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis. Papillomavirus Research.
  • Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. The Lancet.
  • HPV vaccination coverage and course completion rates for Indigenous Australian adolescents, 2015. The Medical Journal of Australia (MJA).
  • Recurrent disease after treatment for cervical pre-cancer: determining whether prophylactic HPV vaccination could play a role in prevention of secondary lesions. CLIMACTERIC.
  • Impact of HPV vaccination: Achievements and future challenges. Papillomavirus Research.
  • The remarkable impact of bivalent HPV vaccine in Scotland. BMJ.
  • Evaluation of self-collected vaginal specimens for the detection of high-risk HPV infection and the prediction of high-grade cervical intraepithelial lesions in a high-burden, low-resource setting. Clinical Microbiology and Infection.
  • Age-specific HPV prevalence among 116,052 women in Australia’s renewed cervical screening program: A new tool for monitoring vaccine impact. Vaccine.
  • Lessons from the renewal of the National Cervical Screening Program in Australia. Public Health Res Pract.
  • Management and long‐term outcomes of women with adenocarcinoma in situ of the cervix: A retrospective study. Aust N Z J Obstet Gynaecol.
  • Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia. Gynecologic Oncology.
  • Is the positive predictive value of high-grade cytology in predicting high-grade cervical disease falling due to HPV vaccination? Int J Cancer.
  • The projected timeframe until cervical cancer elimination in Australia. Lancet Public Health.
  • Clinical validation of the cobas HPV test on the cobas 6800 system for the purpose of cervical screening. J Clin Microbiol.
  • Development and application of a framework to estimate health care costs in China: The cervical cancer example. PLoS ONE.
  • HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control. Papillomavirus Res.
  • Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study. Lancet Public Health.
  • Cancer costs and gender: a snapshot of issues, trends, and opportunities to reduce inequities using Australia as an example. Climacteric.
  • Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates. Public Health.
  • Towards the global elimination of cervical cancer. Papillomavirus Res. 2019.
  • The burden of cervical cancer in Vietnam: Synthesis of the evidence. Cancer Epidemiol.
  • The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications. Gynecol Oncol. 
  • Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study. Lancet Oncol. 
  • Population level impact and herd effects following the introduction of HPV vaccination programs: updated systematic review and meta-analysis, The Lancet.
  • Recombinant HPV 9-valent vaccine in the prevention of cancers caused by HPV, invited review. Infection and Drug Resistance Journal.
  • 9-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population. Gynecologic Oncology.
  • Awareness of HPV cervical cancer and its prevention amongst primigravid antenatal clinic attendees in a tertiary care hospital in Sri Lanka: A cross sectional study. Sexual Health.
  • Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV-16/18 antibodies. Cancer Medicine.
  • Routine cervical screening by primary HPV testing: Early observations from the renewed National Cervical Screening program. The Medical Journal of Australia, (MJA).
  • HPV genoprevalence and HPV knowledge in young women in Mongolia, 5 years following a pilot 4-valent HPV vaccine campaign.  Papillomavirus Research.
  • Prevalence of HPV in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia; 2014-2017. Vaccine.
  • Human papillomavirus testing as part of the renewed National Cervical Screening Program. . Australian Journal of General Practice.
  • HPV vaccination in Papua New Guinea to prevent cervical cancer in women: Gender, sexual morality, outsiders and the de-feminization of the HPV vaccine. Papillomavirus Res.
  • Immunisation coverage annual report, 2017. Commun Dis Intell.
  • Rationalizing the HPV vaccination schedule: a long road to a worthwhile destination. Papillomavirus Research.
  • Understanding the participation of cervical cancer screening among Muslim women in Victoria, Australia from record-linkage data. Journal of Cancer Policy.
  • Australian Paediatric Surveillance Unit Annual Report 2018. Commun Dis Intell.
  • Vaccine Preventable Diseases and Vaccination Coverage in Aboriginal and Torres Strait Islander People, Australia, 2011-2015.
  • HPV vaccination coverage and course completion rates among Aboriginal and Torres Strait Islander adolescents. Med J Aust.
  • Cancer management in the Pacific region: a report on innovation and good practice. Lancet Oncol.

 

 

 

 

 

Useful Links

Proudly funded by

Partners

© 2023 Australian Centre for the Prevention of Cervical Cancer

Search